5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 1.87▼ | 1.91▼ |
MA10 | N/A | N/A | N/A | 1.91▼ | 1.93▼ |
MA20 | N/A | N/A | N/A | 1.92▼ | 2.10▼ |
MA50 | N/A | N/A | N/A | 1.95▼ | 2.76▼ |
MA100 | N/A | N/A | N/A | 2.17▼ | 3.33▼ |
MA200 | N/A | N/A | N/A | 2.74▼ | 4.27▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | -0.013▼ | 0.024▲ |
RSI | N/A | N/A | N/A | 25.859▼ | 31.942▼ |
STOCH | N/A | N/A | N/A | 36.111 | 42.411 |
WILL %R | N/A | N/A | N/A | -66.667 | -85.401▼ |
CCI | N/A | N/A | N/A | -223.441▼ | -97.664 |
CDL | $AST.L Doji Candlestick Pattern Detected | Set Alert |
Thursday, July 25, 2024 07:06 AM
Cambridge, Massachusetts-based Pinetree Therapeutics has entered into an exclusive option and global license agreement with Cambridge, UK-based AstraZeneca .
|
Thursday, July 25, 2024 05:07 AM
Shares of AstraZeneca (NASDAQ:AZN) (LON:AZN) dropped on Thursday after the company reported that other operating income is expected to "decrease substantially". This forecast contrasts with FY 2023, ...
|
Thursday, July 25, 2024 03:25 AM
Our writer takes a closer look at this growth stock -- which also happens to be the largest company of the FTSE 100 -- after its earnings report. The post AstraZeneca, a mega-cap growth stock that ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/07/24 | 1.80 | 1.80 | 1.70 | 1.80 | 50,000 |
24/07/24 | 1.85 | 1.90 | 1.70 | 1.80 | 833,513 |
23/07/24 | 1.90 | 1.90 | 1.85 | 1.85 | 575,000 |
22/07/24 | 1.95 | 2.00 | 1.90 | 1.95 | 1,078,947 |
19/07/24 | 1.95 | 2.00 | 1.90 | 1.95 | 1,078,947 |
17/07/24 | 1.95 | 1.95 | 1.90 | 1.95 | 800,000 |
16/07/24 | 1.95 | 2.00 | 1.902 | 1.95 | 59,573 |
15/07/24 | 1.95 | 1.95 | 1.90 | 1.95 | 5,051 |
12/07/24 | 1.95 | 1.95 | 1.90 | 1.95 | 63,841 |
11/07/24 | 1.95 | 1.969 | 1.90 | 1.95 | 337,403 |
|
|
||||
|
|
||||
|
|